The role of heparan sulfate proteoglycans for tau pathology in vivo

Barbara E Stopschinski, Sandi‐Jo Estill‐Terpack, Sushobhna Batra, Shubhangi Pandey, Jaime Vaquer‐Alicea III, Marc I Diamond · 2025

Read The role of heparan sulfate proteoglycans for tau pathology in vivo by Barbara E Stopschinski, Sandi‐Jo Estill‐Terpack, Sushobhna Batra, Shubhangi Pandey, Jaime Vaquer‐Alicea III, Marc I Diamond (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710292.txt.

Description

Barbara Stopschinski and co-authors test in a 2025 study whether surface sugar coats gate tau spread in living brains. The prion style model says tau seeds hop between cells to spread disease. Past dish work showed those seeds dock on heparan sulfate chains before entry.

One sugar editing enzyme, NDST1, proved key to that docking in cell models. Gene knockout and rescue runs in human cells anchor the new in vivo push. Heparin tests in mouse neurons and astrocytes extend the uptake checks. A virus delivered silencer targets the enzyme in a tauopathy mouse line. The stepwise plan validates the sugar coat as a drug target candidate.

Catalog record

CREATORBarbara E Stopschinski, Sandi‐Jo Estill‐Terpack, Sushobhna Batra, Shubhangi Pandey, Jaime Vaquer‐Alicea III, Marc I Diamond
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710292

Browse the full library · About the Tower of Babel